XML 49 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
NeuVaxTM Acquisition (Purchase Price Consideration and Allocation of Purchase Price) (Detail) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Apr. 13, 2011
Calculation of allocable purchase price:        
Fair value of shares issued at closing including escrowed shares expected to be released     $ 6,367  
Estimated value of earn-out     6,460 6,460
Total allocable purchase price 0 0 12,827  
Allocation of purchase price:        
Cash     168  
Prepaid expenses and other current assets     14  
Equipment and furnishings     11  
Goodwill     5,898  
In-process research and development     12,864  
Accounts payable     (931)  
Accrued expenses and other current liabilities     (143)  
Notes payable     (1)  
Deferred tax liability, non-current     (5,053)  
Total allocable purchase price $ 0 $ 0 $ 12,827